Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: zurdo who wrote (3872)	7/1/1998 10:48:00 PM
From: Mkilloran	Respond to of 9523

zurdo...agree Viagra is the drug of choise....it's just not for everyone. Muse will have the group that Viagra doesn't work on as well as the sub-set of patients on selected meds that conflict with Viagra. I don't understand some of these bitter battles between the posters on each board either. 10 -15% of a 4-5 billion dollar industry is a windfall to a small company like Vivus.... Viagra will IMO beef up its warning labels as more is learned. Foreign countries will evaluate the Viagra introduction in the USA and adopt their own regulations to avoid some potential abuses of Viagra. Both will survive.....in the ED market place. As far as the stock prices...IMO VVUS is oversold and PFE will have a temp pullback maybe to the mid 90's then rise again...